294 related articles for article (PubMed ID: 22274652)
1. Molecular imaging of matrix metalloproteinases in atherosclerotic plaques.
Lenglet S; Thomas A; Chaurand P; Galan K; Mach F; Montecucco F
Thromb Haemost; 2012 Mar; 107(3):409-16. PubMed ID: 22274652
[TBL] [Abstract][Full Text] [Related]
2. Matrix-metalloproteinases as imaging targets for inflammatory activity in atherosclerotic plaques.
Schäfers M; Schober O; Hermann S
J Nucl Med; 2010 May; 51(5):663-6. PubMed ID: 20439506
[TBL] [Abstract][Full Text] [Related]
3. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers.
Skjøt-Arkil H; Barascuk N; Register T; Karsdal MA
Assay Drug Dev Technol; 2010 Oct; 8(5):542-52. PubMed ID: 20662734
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):265-82. PubMed ID: 17338671
[TBL] [Abstract][Full Text] [Related]
6. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular outcome.
Peeters W; Moll FL; Vink A; van der Spek PJ; de Kleijn DP; de Vries JP; Verheijen JH; Newby AC; Pasterkamp G
Eur Heart J; 2011 Sep; 32(18):2314-25. PubMed ID: 21289041
[TBL] [Abstract][Full Text] [Related]
7. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
8. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture.
Newby AC
Physiol Rev; 2005 Jan; 85(1):1-31. PubMed ID: 15618476
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
[TBL] [Abstract][Full Text] [Related]
10. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
Shah PK; Falk E; Badimon JJ; Fernandez-Ortiz A; Mailhac A; Villareal-Levy G; Fallon JT; Regnstrom J; Fuster V
Circulation; 1995 Sep; 92(6):1565-9. PubMed ID: 7664441
[TBL] [Abstract][Full Text] [Related]
11. The role of matrix metalloproteinases in atherothrombosis.
Ketelhuth DF; Bäck M
Curr Atheroscler Rep; 2011 Apr; 13(2):162-9. PubMed ID: 21271310
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis ZS; Khatri JJ
Circ Res; 2002 Feb; 90(3):251-62. PubMed ID: 11861412
[TBL] [Abstract][Full Text] [Related]
13. Carotid atherosclerotic plaques stabilize after stroke: insights into the natural process of atherosclerotic plaque stabilization.
Peeters W; Hellings WE; de Kleijn DP; de Vries JP; Moll FL; Vink A; Pasterkamp G
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):128-33. PubMed ID: 18931283
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation.
Newby AC
Matrix Biol; 2015; 44-46():157-66. PubMed ID: 25636537
[TBL] [Abstract][Full Text] [Related]
15. Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability?
Hermann S; Starsichova A; Waschkau B; Kuhlmann M; Wenning C; Schober O; Schäfers M
J Nucl Cardiol; 2012 Jun; 19(3):609-17. PubMed ID: 22477642
[TBL] [Abstract][Full Text] [Related]
16. [Matrix metalloproteinases and atherosclerosis].
Fic P; Zakrocka I; Kurzepa J; Stepulak A
Postepy Hig Med Dosw (Online); 2011 Jan; 65():16-27. PubMed ID: 21357991
[TBL] [Abstract][Full Text] [Related]
17. Do metalloproteinases destabilize vulnerable atherosclerotic plaques?
Newby AC
Curr Opin Lipidol; 2006 Oct; 17(5):556-61. PubMed ID: 16960505
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in atherothrombosis.
Bäck M; Ketelhuth DF; Agewall S
Prog Cardiovasc Dis; 2010; 52(5):410-28. PubMed ID: 20226959
[TBL] [Abstract][Full Text] [Related]
19. The vulnerable, or high-risk, atherosclerotic plaque: noninvasive MR imaging for characterization and assessment.
Saam T; Hatsukami TS; Takaya N; Chu B; Underhill H; Kerwin WS; Cai J; Ferguson MS; Yuan C
Radiology; 2007 Jul; 244(1):64-77. PubMed ID: 17581895
[TBL] [Abstract][Full Text] [Related]
20. Extracellular proteolysis in the development and progression of atherosclerosis.
Lijnen HR
Biochem Soc Trans; 2002 Apr; 30(2):163-7. PubMed ID: 12023844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]